Hyperfibrinolysis: Difference between revisions
CSV import |
CSV import |
||
| Line 37: | Line 37: | ||
{{stub}} | {{stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 14:32, 17 March 2025
Hyperfibrinolysis is a condition characterized by an increased rate of fibrinolysis, the process that breaks down blood clots. This can lead to excessive bleeding and is often associated with conditions such as trauma, surgery, and certain diseases.
Causes[edit]
Hyperfibrinolysis can be caused by a variety of factors, including:
- Trauma: Severe injury can trigger hyperfibrinolysis as the body attempts to prevent blood clot formation.
- Surgery: Certain surgical procedures, particularly those involving the heart or blood vessels, can lead to hyperfibrinolysis.
- Diseases: Certain diseases, such as liver disease, cancer, and sepsis, can cause hyperfibrinolysis.
Symptoms[edit]
The primary symptom of hyperfibrinolysis is excessive bleeding. This can occur both externally, such as from a wound, and internally, leading to hemorrhage. Other symptoms can include:
- Bruising
- Fatigue
- Shortness of breath
- Pain in the affected area
Diagnosis[edit]
Diagnosis of hyperfibrinolysis typically involves blood tests to measure the levels of fibrinogen, a protein involved in blood clotting, and D-dimer, a product of fibrinolysis. Imaging tests, such as ultrasound or CT scan, may also be used to identify internal bleeding.
Treatment[edit]
Treatment for hyperfibrinolysis typically involves addressing the underlying cause. This may include:
- Medication: Drugs that inhibit fibrinolysis, such as tranexamic acid, may be used.
- Surgery: In cases where hyperfibrinolysis is caused by a physical injury, surgery may be necessary to repair the damage and stop the bleeding.
- Blood transfusion: In severe cases, a blood transfusion may be necessary to replace lost blood.


